Advertisement

The AAPS Journal

, Volume 10, Issue 3, pp 435–438 | Cite as

Evaluation of Nanosuspensions for Absorption Enhancement of Poorly Soluble Drugs: In Vitro Transport Studies Across Intestinal Epithelial Monolayers

  • T. Lenhardt
  • G. Vergnault
  • P. Grenier
  • D. Scherer
  • P. Langguth
Brief/Technical Note

Key words

absorption bioavailability enhancement Caco-2 cells low soluble drugs nanosuspensions 

References

  1. 1.
    G. C. Rao, M. S. Kumar, N. Mathivanan, and M. E. Rao. Nanosuspensions as the most promising approach in nanoparticulate drug delivery systems. Pharmazie. 59(1):5–9 (2004).PubMedGoogle Scholar
  2. 2.
    J. B. Dressman, G. L. Amidon, C. Reppas, and V. P. Shah. Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms. Pharm Res. 15(1):11–22 (1998).PubMedCrossRefGoogle Scholar
  3. 3.
    D. Horter, and J. B. Dressman. Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. Adv Drug Deliv Rev. 46(1–3):75–87 (2001).PubMedCrossRefGoogle Scholar
  4. 4.
    E. Merisko-Liversidge, G. G. Liversidge, and E. R. Cooper. Nanosizing: a formulation approach for poorly-water-soluble compounds. Eur J Pharm Sci. 18(2):113–120 (2003).PubMedCrossRefGoogle Scholar
  5. 5.
    M. Mosharraf, T. Sebhatu, and C. Nystrom. The effects of disordered structure on the solubility and dissolution rates of some hydrophilic, sparingly soluble drugs. Int J Pharm. 177(1):29–51 (1999).PubMedCrossRefGoogle Scholar
  6. 6.
    R. H. Muller, C. Jacobs, and O. Kayser. Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. Adv Drug Deliv Rev. 47(1):3–19 (2001).PubMedCrossRefGoogle Scholar
  7. 7.
    K. Kreuter. Peroral administration of nanoparticles. Advanced Drug Delivery Reviews. 7:71–86 (1991).CrossRefGoogle Scholar
  8. 8.
    G. Wilson. Cell culture techniques for the study of drug transport. Eur J Drug Metab Pharmacokinet. 15(2):159–163 (1990).PubMedGoogle Scholar
  9. 9.
    P. Artursson. Cell cultures as models for drug absorption across the intestinal mucosa. Crit Rev Ther Drug Carrier Syst. 8(4):305–330 (1991).PubMedGoogle Scholar
  10. 10.
    M. Gupta, and H. N. Bhargava. Development and validation of a high-performance liquid chromatographic method for the analysis of budesonide. J Pharm Biomed Anal. 40(2):423–428 (2006).PubMedCrossRefGoogle Scholar
  11. 11.
    S. F. Cooper, R. Masse, and R. Dugal. Comprehensive screening procedure for diuretics in urine by high-performance liquid chromatography. J Chromatogr. 489(1):65–88 (1989).PubMedCrossRefGoogle Scholar
  12. 12.
    P. Artursson. Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells. J Pharm Sci. 79(6):476–482 (1990).PubMedCrossRefGoogle Scholar
  13. 13.
    P. Artursson, and J. Karlsson. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem Biophys Res Commun. 175(3):880–885 (1991).PubMedCrossRefGoogle Scholar
  14. 14.
    C. Hilgendorf, H. Spahn-Langguth, C. G. Regardh, E. Lipka, G. L. Amidon, and P. Langguth. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside-and outside-directed carrier-mediated transport. J Pharm Sci. 89(1):63–75 (2000).PubMedCrossRefGoogle Scholar
  15. 15.
    P. Langguth, A. Hanafy D. Frenzel et al. Nanosuspension formulations for low-soluble drugs: pharmacokinetic evaluation using spironolactone as model compound. Drug Dev Ind Pharm. 31(3):319–329 (2005).PubMedGoogle Scholar

Copyright information

© American Association of Pharmaceutical Scientists 2008

Authors and Affiliations

  • T. Lenhardt
    • 1
  • G. Vergnault
    • 2
  • P. Grenier
    • 2
  • D. Scherer
    • 3
  • P. Langguth
    • 1
  1. 1.Department of Biopharmaceutics and Pharmaceutical TechnologyJohannes Gutenberg-University MainzMainzGermany
  2. 2.SkyePharma AGMuttenzSwitzerland
  3. 3.ApisPharma AGLaufenSwitzerland

Personalised recommendations